Nicholas Lorusso
Stock Analyst at TD Cowen
(3.71)
# 1,905
Out of 4,670 analysts
16
Total ratings
50%
Success rate
33.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Nicholas Lorusso
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMTX Immatics | Maintained: Buy | n/a | $9.09 | - | 5 | Aug 19, 2026 | |
| ARVN Arvinas | Maintained: Hold | n/a | $9.26 | - | 1 | Aug 4, 2026 | |
| KROS Keros Therapeutics | Rated: Hold | n/a | $10.61 | - | 3 | Aug 4, 2026 | |
| KNSA Kiniksa Pharmaceuticals International, | Maintained: Buy | $65 → $95 | $79.49 | +19.51% | 7 | Jul 28, 2026 |
Immatics
Aug 19, 2026
Maintained: Buy
Price Target: n/a
Current: $9.09
Upside: -
Arvinas
Aug 4, 2026
Maintained: Hold
Price Target: n/a
Current: $9.26
Upside: -
Keros Therapeutics
Aug 4, 2026
Rated: Hold
Price Target: n/a
Current: $10.61
Upside: -
Kiniksa Pharmaceuticals International,
Jul 28, 2026
Maintained: Buy
Price Target: $65 → $95
Current: $79.49
Upside: +19.51%